Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

PROMISE III: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia

NCT: NCT05313165 · RECRUITING

NCT IDNCT05313165

StatusRECRUITING

Start Date2022-12-22

Completion2027-05-01

Brief Summary

A prospective, single-arm, multi-center study designed to gather additional information on the LimFlow System.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑